ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 68 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $178,000 | +134.2% | 126,000 | +100.0% | 0.01% | +40.0% |
| Q2 2020 | $76,000 | +2.7% | 63,000 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $74,000 | -44.4% | 63,000 | 0.0% | 0.01% | -36.8% |
| Q4 2019 | $133,000 | -4.3% | 63,000 | 0.0% | 0.02% | -17.4% |
| Q3 2019 | $139,000 | -12.6% | 63,000 | 0.0% | 0.02% | -39.5% |
| Q2 2019 | $159,000 | – | 63,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 62,000 | $216,000 | 0.20% |
| Monashee Investment Management LLC | 187,190 | $651,000 | 0.15% |
| Cedar Wealth Management, LLC | 46,395 | $161,000 | 0.10% |
| BCWM, LLC | 35,100 | $122,000 | 0.06% |
| Tibra Equities Europe Ltd | 149,595 | $521,000 | 0.05% |
| Ahrens Investment Partners LLC | 30,900 | $108,000 | 0.05% |
| ExodusPoint Capital Management, LP | 151,904 | $529,000 | 0.04% |
| Laurion Capital Management LP | 833,400 | $2,900,000 | 0.04% |
| Alpine Global Management, LLC | 33,928 | $118,000 | 0.03% |
| Cornerstone Capital, Inc. | 57,550 | $200,000 | 0.03% |